Generation of integration-free human induced pluripotent stem cell line MUi040-A derived from CD34 + hematopoietic stem cells of a patient with constitutional pericentric inversion of chromosome 9
The MUi040-A human induced pluripotent stem cell (hiPSC) line was established from CD34 + hematopoietic stem cells of a male patient with senile amyloidosis. Patient carries a unique chromosome inversion at bands 9p12 and 9q13, which is one of the most common variants of the normal karyotype of chromosome 9 (inv[9]). This hiPSC line maintains an identical karyotype to that of the parental cells. MUi040-A expressed pluripotency markers and demonstrated the capacity to differentiate into all three germ layers. This cell line offers a valuable in vitro for studying the pathophysiology of senile systemic amyloidosis and for evaluating potential therapeutic approaches.
Authors
- Nithi Asavapanumas (ORCID: https://orcid.org/0000-0002-5362-2124)
- Yongyut Pewkliang (ORCID: https://orcid.org/0000-0003-2267-7883)
- Aung Khine Linn (ORCID: https://orcid.org/0000-0001-8197-2554)
- Suradej Hongeng (ORCID: https://orcid.org/0000-0002-7376-9393)
- Suparerk Borwornpinyo (ORCID: https://orcid.org/0000-0001-6211-3615)
- Teerapat Yingchoncharoen (ORCID: https://orcid.org/0000-0001-5689-2704)
- Objoon Trachoo (ORCID: https://orcid.org/0000-0001-7867-3238)
- Alisa Tubsuwan (ORCID: https://orcid.org/0000-0003-2412-6102)
- Pirut Tong‐ngam
- Phetcharat Phanthong (ORCID: https://orcid.org/0000-0003-3758-2676)
- Wanida Laosee
Institutions
- Mahidol University (TH)
- Ramathibodi Hospital (TH)
Publication Details
- Journal
- Stem Cell Research
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.scr.2025.103866
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00